These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 15569998

  • 1. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L, Monfils B, Calabresi P.
    Clin Cancer Res; 2004 Nov 15; 10(22):7655-61. PubMed ID: 15569998
    [Abstract] [Full Text] [Related]

  • 2. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
    Calabresi P, Goulette FA, Darnowski JW.
    Cancer Res; 2001 Sep 15; 61(18):6816-21. PubMed ID: 11559556
    [Abstract] [Full Text] [Related]

  • 3. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Sun BS, Wang JH, Liu LL, Gong SL, Redmond HP.
    J Surg Oncol; 2007 Sep 01; 96(3):241-8. PubMed ID: 17469118
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
    Darnowski JW, Goulette FA, Cousens LP, Chatterjee D, Calabresi P.
    Cancer Chemother Pharmacol; 2004 Sep 01; 54(3):249-58. PubMed ID: 15173956
    [Abstract] [Full Text] [Related]

  • 5. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
    Opitz I, Sigrist B, Hillinger S, Lardinois D, Stahel R, Weder W, Hopkins-Donaldson S.
    Lung Cancer; 2007 Jun 01; 56(3):327-36. PubMed ID: 17383050
    [Abstract] [Full Text] [Related]

  • 6. Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma.
    Aceto N, Bertino P, Barbone D, Tassi G, Manzo L, Porta C, Mutti L, Gaudino G.
    Eur Respir J; 2009 Dec 01; 34(6):1399-407. PubMed ID: 19460788
    [Abstract] [Full Text] [Related]

  • 7. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 01; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
    Stendel R, Scheurer L, Stoltenburg-Didinger G, Brock M, Möhler H.
    Anticancer Res; 2003 Feb 01; 23(3B):2309-14. PubMed ID: 12894508
    [Abstract] [Full Text] [Related]

  • 9. MAPK regulation and caspase activation are required in DMNQ S-52 induced apoptosis in Lewis lung carcinoma cells.
    Lee SJ, Sakurai H, Koizumi K, Song GY, Bae YS, Kim HM, Kang KS, Surh YJ, Saiki I, Kim SH.
    Cancer Lett; 2006 Feb 20; 233(1):57-67. PubMed ID: 15893420
    [Abstract] [Full Text] [Related]

  • 10. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML, Redmond HP, Bouchier-Hayes DJ.
    J Surg Res; 2001 Dec 20; 101(2):111-9. PubMed ID: 11735264
    [Abstract] [Full Text] [Related]

  • 11. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 12. The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model.
    Braumann C, Jacobi CA, Rogalla S, Menenakos C, Fuehrer K, Trefzer U, Hofmann M.
    J Surg Res; 2007 Dec 15; 143(2):372-8. PubMed ID: 17612567
    [Abstract] [Full Text] [Related]

  • 13. Identification of caspase-independent apoptosis in epithelial and cancer cells.
    Cummings BS, Kinsey GR, Bolchoz LJ, Schnellmann RG.
    J Pharmacol Exp Ther; 2004 Jul 15; 310(1):126-34. PubMed ID: 15028782
    [Abstract] [Full Text] [Related]

  • 14. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I, Weizman A.
    Oncol Rep; 2006 Jan 15; 15(1):107-12. PubMed ID: 16328041
    [Abstract] [Full Text] [Related]

  • 15. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
    Rodak R, Kubota H, Ishihara H, Eugster HP, Könü D, Möhler H, Yonekawa Y, Frei K.
    J Neurosurg; 2005 Jun 15; 102(6):1055-68. PubMed ID: 16028765
    [Abstract] [Full Text] [Related]

  • 16. The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism.
    Han Z, Ribbizi I, Pantazis P, Wyche J, Darnowski J, Calabresi P.
    Anticancer Res; 2002 Jun 15; 22(4):1959-64. PubMed ID: 12174870
    [Abstract] [Full Text] [Related]

  • 17. The effect of taurolidine on brain tumor cells.
    Stendel R, Stoltenburg-Didinger G, Al Keikh CL, Wattrodt M, Brock M.
    Anticancer Res; 2002 Jun 15; 22(2A):809-14. PubMed ID: 12014655
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
    Ferguson D, Rodriguez LE, Palma JP, Refici M, Jarvis K, O'Connor J, Sullivan GM, Frost D, Marsh K, Bauch J, Zhang H, Lin NH, Rosenberg S, Sham HL, Joseph IB.
    Clin Cancer Res; 2005 Apr 15; 11(8):3045-54. PubMed ID: 15837760
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma.
    Esposito V, Palescandolo E, Spugnini EP, Montesarchio V, De Luca A, Cardillo I, Cortese G, Baldi A, Chirianni A.
    Clin Cancer Res; 2006 Apr 15; 12(8):2634-9. PubMed ID: 16638877
    [Abstract] [Full Text] [Related]

  • 20. Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
    Brignole C, Marimpietri D, Pastorino F, Nico B, Di Paolo D, Cioni M, Piccardi F, Cilli M, Pezzolo A, Corrias MV, Pistoia V, Ribatti D, Pagnan G, Ponzoni M.
    J Natl Cancer Inst; 2006 Aug 16; 98(16):1142-57. PubMed ID: 16912267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.